Viridian Therapeutics (VRDN)
(Delayed Data from NSDQ)
$12.17 USD
-0.06 (-0.49%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $12.17 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
Viridian Therapeutics, Inc. [VRDN]
Reports for Purchase
Showing records 1 - 20 ( 86 total )
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
We Are Confident in VRDN-001''s Efficacy, But Being Conservative With the TED Market Size
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Execution Matters -- THRIVE Setting Up For ~September, THRIVE-2 YE24
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
TED KOL Check: Untangling The TED Therapeutic Landscape
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
INVITE: TED KOL Check -- Untangling The TED Therapeutic Landscape
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Make Sure To Read Fine Print; Lonigutamab Update/Read Through To VRDN
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Pipeline Continues to THRIVE --- Awaiting Pivotal Data By Mid-2024
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Kickstart or False Start? What January Tells Us about Biotech Annual Returns
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Target In Sight: New Horizon For VRDN With VRDN-003 Nomination
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The TED Trifecta: Setting the Stage Ahead of SC TED Strategic Update
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VRDN 112223
Provider: Stock Traders Daily
Analyst: Research Department